Clinical Trial Update: A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 trial to evaluate Rimegepant (Nurtec ODT) in adolescents with frequent migraines. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 3 | Status: RECRUITING